PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'West Virginia University School of Medicine, Morgantown, WV 26506, United States of America. Electronic address: haggertyt@hsc.wvu.edu.\', \'West Virginia Clinical and Translational Science Institute, Morgantown, WV 26506, United States of America.\', \'West Virginia University School of Medicine, Morgantown, WV 26506, United States of America.\', \'West Virginia Board of Pharmacy, 2310 Kanawha Blvd, Charleston, WV 25311, United States of America.\', \'West Virginia University School of Public Health, Department of Epidemiology, Morgantown, WV 26506, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0740-5472(21)00413-X10.1016/j.jsat.2021.108687
?:doi
?:hasPublicationType
?:journal
  • Journal of substance abuse treatment
is ?:pmid of
?:pmid
?:pmid
  • 34903397
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.311
?:rankingScore_hIndex
  • 91
is ?:relation_isRelatedTo_publication of
?:title
  • Assessing the impact of social distancing measures implemented during COVID-19 pandemic on medications for opioid use disorder in West Virginia.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all